SAMH
CRVO icon

Shanda Asset Management Holdings’s CervoMed CRVO Stock Holding History

Shanda Asset Management Holdings’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-813
Closed -$59K – 66
2020
Q2 		$59K Buy
+813
New +$49.5K 0.01% 99

Other funds holding CRVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Shanda Asset Management Holdings's CRVO Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of CervoMed (CRVO) in Q3 2020, closing a stake of 813 shares — an estimated $59K sold.

Shanda Asset Management Holdings first reported a position in CRVO in Q2 2020 and held it in 1 quarter. The position peaked at $59K in Q2 2020. 22 funds tracked by Wall St. Rank hold CRVO as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining CervoMed position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 813 CervoMed shares in Q3 2020, an estimated $59K.
  • Shanda Asset Management Holdings first reported a position in CervoMed in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's CervoMed position peaked at $59K in Q2 2020.
  • 22 funds tracked by Wall St. Rank held CervoMed as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.